S$500,000
- Minimum spending over 3 years
- S$750,000
- Minimum hiring over 3 years
- At least 5
RIS(C) supports foreign-owned companies establishing or expanding substantial R&D and innovation activities in Singapore.
Administered by the Singapore Economic Development Board (EDB).
Standard grant packages connect the scale of support with the R&D expenditure and skilled employment your company commits to build.
These thresholds are not an automatic entitlement. EDB assesses the project's quantitative and qualitative merits and determines the support package. Larger strategic R&D investments may be considered for customised support.
Build a Singapore R&D team, engineering centre or new technology-development programme.
Add a new product platform, research programme or regional or global development responsibility.
Pursue new or significantly improved products and processes through substantive R&D and experimental development.
Up to 60%
Qualifying Singapore-based employees directly involved in the approved project.
Up to 30%
Qualifying foreign technical personnel directly contributing to the project.
Up to 30%
Qualifying equipment required for the approved R&D and innovation activities.
Reeve | R&D connects the technical programme, financial case and Singapore investment rationale, supporting your team through application and Post-Award Management.
Discover our Grant Management approachEstablish project fit, ownership and timing. Define the R&D scope, expenditure, team and three-year commitment.
Develop the technical narrative, financial forecast, milestones and Singapore capability rationale.
Support the application and clarifications. Translate the approved scope and conditions into practical requirements.
Track expenditure, technical progress and milestones; prepare supporting evidence, claims and closure.
Hiring commitments are assessed against the number of employees at the end of the previous financial year. Use that baseline when planning the additional R&D and innovation roles for your three-year project.
Discuss your R&D projectRIS(C) is relevant to companies that are registered or incorporated and operating in Singapore and that intend to undertake a qualifying new R&D or innovation project locally.
A fundamental eligibility condition is the company's ownership profile.
RIS(C) is intended for companies with less than 30% Singaporean / Singapore PR ownership.
This makes it particularly relevant to:
A company can therefore have some Singaporean or PR ownership and still fall within the RIS(C) route, provided local ownership remains below the applicable 30% threshold.
Companies with 30% or more Singaporean / Singapore PR ownership are not eligible for RIS(C) and should assess other support mechanisms.
RIS(C) and the Enterprise Singapore EDGE Grant serve different company profiles.
| RIS(C) | EDGE | |
|---|---|---|
| Agency | Singapore Economic Development Board | Enterprise Singapore |
| Local ownership | Less than 30% Singaporean / PR ownership | At least 30% Singaporean / PR ownership |
| Main focus | Substantive R&D and innovation activity in Singapore | Broader business growth, transformation, innovation and internationalisation |
| Typical applicant | Foreign-owned company / MNC | Locally owned Singapore company |
| Relevant project | New or expanded R&D and innovation capability | Wider range of supported business projects |
For a foreign-owned company establishing or expanding a substantive R&D activity in Singapore, RIS(C) is therefore one of the principal grant routes to assess.
Routine implementation, technology adoption, ordinary production and business-as-usual engineering generally fall outside RIS(C). Transferring an existing capability without new development work is also insufficient.
Having an existing R&D team in Singapore does not necessarily prevent a company from considering RIS(C).
The key question is whether the company is undertaking a new or expanded R&D and innovation programme that represents an additional commitment.
For example, a company may already employ engineers in Singapore but be planning to:
In those circumstances, the incremental project may still justify assessment.
RIS(C) should not, however, be viewed as funding for existing business-as-usual R&D expenditure without a new qualifying project or capability expansion.
RIS(C) can provide support towards qualifying expenditure incurred in carrying out the approved R&D and innovation project.
The principal cost categories are:
Qualifying Singapore-based employees directly involved in the approved project can form a major component of the grant.
Current programme parameters provide support of up to 60% of qualifying local manpower costs.
The relevant personnel must be directly involved in the R&D or innovation activities covered by the award.
Foreign technical personnel directly contributing to the project may also qualify.
Current programme parameters provide support of up to 30% of qualifying foreign manpower costs.
This can be relevant where specialist expertise needs to be brought into Singapore as part of establishing or developing the new R&D capability.
Equipment required to perform the approved R&D and innovation activities may also be supported.
Current programme parameters provide support of up to 30% of qualifying equipment expenditure.
Depending on the approved project, this may include the purchase or eligible financing or leasing cost of equipment together with certain directly related delivery, calibration or installation costs.
The approved grant amount should not be treated as an unconditional lump-sum subsidy.
The amount ultimately claimable depends on:
This makes expenditure planning and Post-Award Management an important part of a RIS(C) project.
Companies undertaking substantial R&D in Singapore should generally consider both grant funding and R&D tax incentives when assessing the economics of the programme.
The two mechanisms operate differently.
RIS(C) provides project-based grant support linked to an approved R&D and innovation programme.
Singapore's R&D tax incentives operate through the corporate tax system and depend on whether the underlying activities and expenditure satisfy the relevant tax requirements.
The same wider R&D programme may therefore need to be considered across both funding and tax workstreams.
However, companies should not assume that the same expenditure can simply receive unrestricted support under multiple government mechanisms. The interaction between the grant award and tax treatment should be reviewed carefully.
A strong RIS(C) project is not assessed only on whether its technical work can be described as innovative.
The wider question is what new R&D and innovation capability the company is committing to build in Singapore.
This can include:
How much qualifying R&D and innovation expenditure will be undertaken locally?
What technical, engineering, scientific or innovation roles will be created or maintained in Singapore?
What new knowledge, technology or development capability will sit within the Singapore operation?
What products, processes, technologies or applications will be developed?
How does the project strengthen Singapore's role within the company's regional or global R&D organisation?
The strongest projects connect these elements into a coherent investment case rather than presenting the application purely as a request for reimbursement of R&D costs.
EDB assesses RIS(C) applications based on both the proposed project and the company undertaking it.
The assessment can include quantitative and qualitative considerations.
These can include:
These can include:
Meeting the expenditure and employment thresholds associated with a standard package does not guarantee that EDB will approve that package.
The application therefore needs to demonstrate both the scale of the commitment and the quality of the proposed R&D programme.
The work does not end when the grant is awarded.
A multi-year RIS(C) project requires continued alignment between the approved project, the company's actual R&D activity and the expenditure being claimed.
Key areas include:
Potential issues are much easier to manage during the qualifying period than at the end of the project when the claim is being reconstructed retrospectively.
Yes. RIS(C) is specifically relevant to companies with less than 30% Singaporean / Singapore PR ownership, making it an important funding route for foreign-owned companies and multinational groups undertaking R&D in Singapore.
A company with 30% or more Singaporean / Singapore PR ownership is not eligible for RIS(C).
Locally owned companies should instead assess relevant Enterprise Singapore funding routes, including the EDGE Grant, depending on the project.
RIS(C) is not defined simply by the global size of the applicant.
EDB considers the proposed R&D project, the company's Singapore commitment, the quality of the activity and the company's ability to implement the programme.
The scheme is nevertheless most commercially relevant where the proposed R&D activity is sufficiently substantial to justify a multi-year R&D and capability commitment in Singapore.
Potentially, where the company is undertaking a new or materially expanded R&D or innovation programme.
It is not intended simply to subsidise ongoing business-as-usual activity.
Yes. A company undertaking qualifying R&D may need to assess both grant and tax incentives.
They operate through different mechanisms, and the treatment of expenditure should be reviewed carefully to avoid assuming that the same costs can receive unrestricted overlapping support.
Bring your planned R&D activities, hiring outlook and expenditure forecast. We can assess the potential funding route and the next steps.
Discuss your R&D project